Welcome to the Hannover House Investor Relations Blog

Wednesday, June 21, 2017

Busy Release Slate for the Post-Merger Summer / Early Fall Months

Good Afternoon HHSE Friends and Crimson Forest Partners - The next few months will see significantly expanded activities, including a release slate and distribution breadth that represents the highest level of consumer visibility ever for Hannover House theatrical releases.

Five titles (two of which have been previously announced) will see theatrical openings on more than 100+ screens beginning in July... and continuing non-stop through October.  The announced titles ("BLOOD FEAST" and "WHERE'S THE DRAGON?") are up first... but three others (which will each be announced individually) are already in queue for August, September and October... resulting in a relentless march of increasingly commercial releases to theatres, These higher-profile theatrical titles will also drive greater placements and revenues into the home video, VOD and SVOD windows in the months following.

A WIRE SERVICES PRESS RELEASE detailing additional information on these national theatrical titles... as well as updates on new PRODUCTIONS, new FINANCING and MERGER (STOCK-SWAP and FILING UPDATES), will be posted today (or pre-market Thursday at the latest). The delay in releasing these updates involves obtaining third-party approvals of release details, as well as attorney review of language relating to the merger updates.

Friday, June 16, 2017

HHSE thanks Academy Award Winner KIM BASINGER for being our "Eternal Goddess!"

Dear HHSE Friends & Followers - we are honored to announce that Golden Globe and Academy Award winning superstar KIM BASINGER has completed her role in the Crimson Forest-Hannover House production of "WHERE'S THE DRAGON?"

Ms. Basinger performed the role of "Eternal Goddess" and was recorded in Santa Monica, CA at Villa Formosa Studios. Crimson Forest Chairman JON LIM and WTD Animation Director SING CHOONG FOO were in attendance, with English-Adaptation director STAR NOORBAKHSH supervising via ISDN from Crisp Recording Studios in Fayetteville, Arkansas. "WHERE'S THE DRAGON?" will be released to theatres nationwide this summer... watch this space for more details!

UPDATE: Tuesday, June 20 - HHSE / CRIMSON FOREST partner with REGAL ENTERTAINMENT GROUP for a high-visibility, national theatrical launch of "WHERE'S THE DRAGON?" opening Friday, August 25.  This date has been selected to maximize family support for this animated feature, and to position the title for ancillary sales success in the following months (Home Video / V.O.D. / S.V.O.D. and Television).  Competitively, in the category of animated family features, THE EMOJI MOVIE is releasing July 28 (Columbia), and the next major animated title is NUT JOB 2 on August 11 (Open Road), and LEAP on August 30 (Weinstein Company). 

Star Noorbakhsh (Foreground) supervises some of the voice-talent performers in "WHERE'S THE DRAGON?" during the recording of the closing credits ensemble song at Crisp Recording Studios.

Thursday, June 15, 2017

... yet another victory for HHSE!

Greetings HHSE Friends & Followers - As reported in this blog, the prior litigation and loan dispute between Hannover House and TCA Global Master Fund was settled quite some time ago, and finally filed with the Florida courts on May 17.  The 10-mm collateral shares have been cancelled, and this matter is closed.

Again, this is ancient news for those reading this blog site (and recognizing the legal obligation HHSE is under to report with full accuracy on the status of issues at the date of such disclosures).  But in respect of those few, remaining naysayers who prefer "willful denial" to truthful reality, here's the court docet listing.  ONWARD!!

Wednesday, June 14, 2017

Be patient, my friends and you will be rewarded

Good morning HHSE Friends & Followers - As the days turn into weeks, some shareholders have lost patience awaiting the final closure of the impending CRIMSON FOREST-HHSE Merger and how that will impact the bottom-line value of their HHSE shares.

We can state unequivocally that the value of the HHSE shares post-merger is substantially over the $.03 / PPS level - and furthermore state that following a lengthy telephone call with FINRA on Monday, that the few, remaining issues impacting the final step (the stock-for-stock swap) are being resolved and will promptly remove any final impediments to the stock exchange.

For those of you who have grown impatient and feel you must sell-sell-sell now, we bid you farewell and safe journeys.  But we also have an obligation to disclose that the stock-for-stock swap is based on a much higher value to HHSE shareholders (regardless of the temporary, day-to-day variations of the current trading price).  Selling now will only hurt those particular sellers, who we suspect may feel rather foolish in the coming days.  As the merger is structured, HHSE shareholders are being issued newly re-branded Crimson shares based on the predetermined level of the company's assets... not based on the momentary trading price of the HHSE stock prior to the swap.

Unless you have an urgent need for liquidity, veteran traders will be sitting it out for this final, brief pre-swap spell. This morning's blog is being posted now, in the final days before the stock-swap, as an advance rebuttal for anyone who might later claim "we didn't know" (about the short time frame to the swap, and the HHSE valuation being established at substantially over $.03 / PPS).  

For those of you hanging on... it's going to be an AMAZING Summer, followed by a consistent and accelerating momentum in revenues and results through the next few years.  This is the "prize" that HHSE management has been working to achieve:  a fully-reporting equity, substantial operational and marketing funding, and a slate of star-driven, high-profile movies to serve as revenue locomotives!  Watch this space...

Tuesday, June 6, 2017

Corporate Updates on Merger Events / Resolutions

Good afternoon HHSE Friends & Followers - In anticipation of our pending merger approval, HHSE has been working with our attorneys and key creditors on the final resolution of some of old issues that have been fuel for stock critics - but which were never material threats to the operations of our business.  Here's a quick recap of some recently resolved matters and pending transactions:

1).   TCA GLOBAL MASTER FUND - as stated previously in this blog, a settlement was made with TCA to fully close all maters... well it's finally been filed with the courts in Florida... as the court-recorded documentation of settlements sometimes occurs weeks / months after the deals are made.  In any event, HHSE stock certificate #1530, issued June 18, 2013 as collateral for the TCA Investment Advisory Fee has been cancelled, and these 10-million shares will be returned as unissued treasury stock.

2).   JSJ INVESTMENTS - Principal terms of a settlement are expected this week, based upon communications between attorneys.

3).   ANDERSONS P&A - Principal terms of a settlement are expected this week, based upon direct communications with the lenders.

4).   BEDROCK VENTURES - Company has engaged counsel to re-open the case under Arkansas Law, as compelling evidence exists to have the California matter vacated.

5).   AMITYVILLE ASYLUM - New counsel has been engaged in this matter, which is expected to be settled (or adjudicated) by June 27.

A separate Blog Posting on Merger activities with Crimson Forest is being prepared for later today.

UPDATE:  Greetings HHSE Friends. The update planned for Tuesday got hijacked by some post-merger funding details that monopolized managerial time for the past two days.  As alluded to in some of our recent, prior blogs and filings, five significant media players (all China-based) will be conducting various financing transactions "post-merger" that will provide production funds, releasing funds and operational resources.  It is our belief that the balance-sheet value and revenue benefits from these various transactions will not only transform the company, but will also elevate the business to a level of qualifying for the NASDAQ exchange.

Meanwhile, here are some quick updates for those issues which we are authorized or empowered to disclose at this time:

1).  MERGER APPROVAL - we have not received any regulatory feedback that would indicate any issues, delays or problems with the valuation methodology and the stock-for-stock swap.  We have separately applied for a Crimson ticker symbol change, and are awaiting word on that matter as well.

2).  DTC / STOCK FOR STOCK SWAP - Our advisors tell us that HHSE shareholders will not need to do anything in order for each of them to receive Crimson Forest shares on the date of the stock-for-stock swap.  Crimson shares are DTC (electronic) and this will avoid the prior issues some shareholder incurred regarding paper certificates from HHSE.

3).  PREMIUM VALUATION - as structured, HHSE shareholder will receive Crimson shares at a significant premium value-to-market.  We cannot disclose the percentage structure until we receive full-regulatory approval.  However, the bottom line is that a shareholder owning "$X" worth of HHSE shares will receive "$X++" of newly re-branded Crimson shares.

4).  CRIMSON SHARE SUPPORT - Contemporaneous with the merger, several of the China-based affiliates will be buying blocks of Crimson stock on the public markets.  It is our belief that this will further support the Crimson share price and result in an even greater appreciation of value for HHSE shareholders.

5).  POST MERGER ACTIVITIES - Besides the launch of several high-profile theatrical productions post-merger, the newly re-branded Crimson-HHSE will be (finally!) launching the VODWIZ portal, and embarking on three, very exciting new distribution ventures involving North American activities, International Sales, and Theatrical Distribution in China.  It is our belief that these significant post-merger activities will have a dramatic impact on the company's revenues, visibility and valuation.

6).  TIME FRAME - we believe that we are only days away from completion of the tasks that are required for the regulatory approval of the stock-for-stock swap, and the physical share exchange.  However, as this time frame is driven by outside agencies, we cannot provide a more specific prediction of the precise day that all of this will be completed.

Sunday, June 4, 2017

Post-Cannes & Merger Follow-Up Blog Post Slated for Tuesday, June 6

Greetings HHSE Friends & Followers - At the request of a good number of legitimate shareholders, we have been asked to release both a "post-Cannes" follow-up report... as well as an update / status blog on the present status of the Crimson Forest-HHSE merger completion.

Both topics require third-party approvals of information (or legal counsel);  accordingly, we have set Tuesday (June 6) as our target date to release whatever level of new information is approved for disclosure at that time.

As stated previously, the Cannes Marche du Film was brisk and productive for the combined entities of Hannover House - Crimson Forest, and there were significant new venture deals structured for an impressive slate of high-profile theatrical titles with major stars.

Also, as per prior disclosures, the two companies (Hannover House and Crimson Forest) are already operating as a combined entity, with the only outstanding issue being the stock-for-stock swap (of Hannover House shares into a newly rebranded Crimson equity); the steps for this final process are well into motion, but require regulatory review and approval which is outside of the direct control of HHSE-Crimson managers.

For a variety of reasons, the Cannes Film Festival and Marche du Film is the unquestioned, dominant world market for high-end films.  The luxurious destination is an attraction for the major buyers, and the costs and obstacles to travel and obtain festival credentials pose obstacles to keep away the sort of peripheral non-industry-outsiders who might otherwise clog the lobby of the AFM Lowes Hotel in Santa Monica. The coveted Cannes Buyer's Badge is the ultimate pass to all locations and major events, but requires multiple, positive-referrals from registered sellers.  So, we have been very honored to have achieved this recognition status for the past four years:  a validation of Hannover's stature, proclaimed by top industry insiders and some of our current and prior program licensors.

Assorted photos from Cannes meetings are below and on prior Cannes blogs...

Sunday, May 21, 2017

What a difference a YEAR makes!! Brisk Cannes Reception for HHSE-Crimson as PreSale Buyer!

Greetings HHSE Friends & Followers - Parkinson and Shefte are enjoying a brisk market reception at CANNES to the news of the Crimson Forest merger - and the combined company's subsequent availability of $65-mm in presale financing for high-end feature film projects.  The caliber of meetings and products being presented is unprecedented for the Company - and lots of deals are being made.  In respect of the caliber of these films, each new acquisition will be announced via a separate and formal press release.  But for now, here's some quick images from the first three days of the 70th Annual Cannes Market for Hannover House / Crimson executives....

Dual Registration as Crimson and Hannover House. 

Fred and Diana Shefte at the TV Rights Dinner.

MAJOR feature announcement (our biggest budgeted film EVER) coming soon between HHSE-Crimson and UK's SILVER LINING Films (Parkinson pictured with Grant Bradley of Silver Lining).

Non-Stop action on the Palais Steps.

Lovely little alcoves, stairways and hidden gems in Canne's historic old town.

The Castle that overlooks the Canes harbor is atop the distant hill.

The Future is Bright - and so is the Cannes Beach (Parkinson really should be wearing shades!)